Compare FDC LTD. with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. FRESENIUS KABI ONCO. FDC LTD./
FRESENIUS KABI ONCO.
 
P/E (TTM) x 16.7 22.1 75.2% View Chart
P/BV x 2.5 3.1 80.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 FDC LTD.   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    FDC LTD.
Mar-18
FRESENIUS KABI ONCO.
Mar-13
FDC LTD./
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs319176 181.3%   
Low Rs16479 208.9%   
Sales per share (Unadj.) Rs61.637.7 163.6%  
Earnings per share (Unadj.) Rs9.95.1 195.3%  
Cash flow per share (Unadj.) Rs12.06.7 178.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs73.242.5 172.0%  
Shares outstanding (eoy) m174.40158.23 110.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.93.4 116.0%   
Avg P/E ratio x24.325.0 97.2%  
P/CF ratio (eoy) x20.218.9 106.6%  
Price / Book Value ratio x3.33.0 110.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m42,11820,135 209.2%   
No. of employees `0005.51.2 480.1%   
Total wages/salary Rs m2,167703 308.1%   
Avg. sales/employee Rs Th1,943.75,176.2 37.6%   
Avg. wages/employee Rs Th391.7610.4 64.2%   
Avg. net profit/employee Rs Th313.7699.6 44.8%   
INCOME DATA
Net Sales Rs m10,7515,963 180.3%  
Other income Rs m51018 2,831.1%   
Total revenues Rs m11,2605,981 188.3%   
Gross profit Rs m2,2671,430 158.5%  
Depreciation Rs m351258 136.3%   
Interest Rs m14-26 -53.8%   
Profit before tax Rs m2,4111,216 198.2%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m671342 196.1%   
Profit after tax Rs m1,735806 215.3%  
Gross profit margin %21.124.0 87.9%  
Effective tax rate %27.828.1 98.9%   
Net profit margin %16.113.5 119.4%  
BALANCE SHEET DATA
Current assets Rs m7,2135,102 141.4%   
Current liabilities Rs m2,1042,385 88.2%   
Net working cap to sales %47.545.6 104.3%  
Current ratio x3.42.1 160.3%  
Inventory Days Days54150 36.3%  
Debtors Days Days28113 24.5%  
Net fixed assets Rs m6,8655,148 133.3%   
Share capital Rs m175158 110.7%   
"Free" reserves Rs m12,5866,556 192.0%   
Net worth Rs m12,7616,732 189.6%   
Long term debt Rs m6952 0.6%   
Total assets Rs m15,04110,388 144.8%  
Interest coverage x173.2-45.8 -378.4%   
Debt to equity ratio x00.1 0.3%  
Sales to assets ratio x0.70.6 124.5%   
Return on assets %11.67.5 154.9%  
Return on equity %13.612.0 113.6%  
Return on capital %19.014.6 129.8%  
Exports to sales %12.374.5 16.6%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs m1,3274,441 29.9%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m1,8895,298 35.7%   
Fx outflow Rs m01,772 0.0%   
Net fx Rs m1,8893,525 53.6%   
CASH FLOW
From Operations Rs m1,4981,274 117.6%  
From Investments Rs m201-1,204 -16.7%  
From Financial Activity Rs m-1,694-196 864.0%  
Net Cashflow Rs m10-126 -8.2%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 4.7 0.3 1,566.7%  
FIIs % 7.5 9.6 78.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 9.1 208.8%  
Shareholders   23,730 42,599 55.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ORCHID PHARMA LTD  CIPLA  ABBOTT INDIA  SUVEN LIFESCIENCES  WYETH LTD  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Nov 15, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS